ABSTRACT The Lambeth Conventions are guidelines intended to be of practical value in the investigation of arrhythmias induced by ischaemia, infarction, and reperfusion. They cover the design and execution of experiments and the definition, classification, quantification, and analysis of arrhythmias. Investigators are encouraged to adopt the conventions in the hope that this will improve uniformity and interlaboratory comparisons.
Introduction
We met in London in April 1987 to draw up guidelines for research on the arrhythmias induced by myocardial ischaemia, infarction, and reperfusion. Experiments often lack Uniformity, and terminology is lax and subjective. To rectify this, a radical approach avoiding "the paralyzing influence of the dead hand of tradition" was needed. '
The conventions had to be of practical value in terms of the design, execution, and analysis of experiments, with emphasis on the definition, classification, and quantification of ventricular premature beats (VPB), ventricular tachycardia (VT), and ventricular fibrillation (VF). We aimed for scientific appropriateness, but some decisions were arbitrarily taken; for example, since we were unable to give a convincing reason why any one number of consecutive ventricular premature beats was scientifically more correct than any other in defining ventricular tachycardia we chose a number by common consent. studies. A study of only one or two doses will determine only whether those particular doses were effective; it will not permit a reliable estimate of potency or a generalisation on mechanisms of action. However, in clinical studies, ethical considerations may pre-empt a dose-response study. Comparisons of structurally related congeners or optical enantiomers and array type designs increase the analytical power of a study.
Is there a requirement forpilot studies? (convention 3)
The selection of an appropriate dose range in a large, blinded, dose-response study avoids unnecessary experiments. Preceding open pilot studies should be reported only in the methods section.
Are there preferred species of animal and choices of model? (convention 4 )
The objectives of a study determine the choice of preparation (animal or heart); no species or model can be regarded as ideal. Consequently, the limitations of a model should be appreciated.
Should the source, diet, and housing of animals be reported? (convention 5 )
The background details of an experiment (whether considered to be immediately relevant or not) should be briefly outlined. Arrhythmias, for exam le, may be and may vary between species' and between strains of a single species (Riemersma R A, unpublished data).
In man, sudden cardiac death is subject to circadian rhythm' and varies with age, sex, and diet. ' In theory it is simple to control the diet, but in practice it may be virtually impossible because the content of commercial feeds can be changed from batch to batch without notice. If possible, therefore, there should be enough feed in stock at the start to last throughout a study.
To reduce intralaboratory variability, animals should come from a regular (and specified) source. When, as may happen with large animals, a single supplier cannot meet the demand, the institute animal house should be specified as the source of supply.
What types of controls are appropriate? (convention 6 )
When it is wished to compare an intervention with no intervention, one requires untreated (negative) controls. To examine whether aspects of the interventions, such as drug vehicle, contribute to any effect the necessary controls may be defined as neutral controls. To isolate the role of a particular property of an intervention (such as its ability to lower blood pressure) in order to examine the role of this property in its antiarrhythmic effect positive controls (such as vasodilators) are required. However, since each positive control group will have its own set of positive and neutral controls, and so on. we have not made a list of mandatory controls.
influenced by animal housing conditions' P .
and diet"6 Controls must be randomised into a study and be contemporary with the intervention. Numerically, they should be of the same size as the intervention group or, at least, a statistically acceptable percentage thereof. Historical controls should be used only if it can be proved that values of their variables do not differ from those that would be present in contemporary controls. However, to prove this, a contemporary control group is required, thereby defeating the main object of using historical controls.
In the present state of arrhythmia research we cannot recommend that a preparation be allowed to act as its own control because this requires, a priori, repeated episodes of ischaemia. On the one hand, ischaemia induced arrhythmias following a second occlusion may be similar to those induced by the first," but on the other, repeated episodes of ischaemia may jeopardise an experiment; changes in myocardial pH and potassium concentration differ from first to second occlusions," and brief periods of ischaemia may protect against the arrhythmogenicity of reperfusion after a second period of ischaemia.12 More experiments are needed to study the appropriateness of using a preparation as its own control. Should exclusion criteria be specified? (convention 7 ) Exclusion criteria (defined as rules for replacing a preparation which is compromised to the extent that the value of the experiment is jeopardised) must be clearly defined before the start of study and must be applied blindly. Once the criteria have been decided, the number of preparations excluded and the reasons why should be reported in detail. How can experimental conditions be veri$ed? (convention 8 ) For models of global ischaemia and reperfusion, coronary flow is an independent variable (that is, it is controlled by the investigator), but in models of regional ischaemia (with or without reperfusion) and infarction the experimental conditions must be verified and quantified.
In animals whose coronary circulations have few coronary collaterals (for example, pig, rabbit, and rat) coronary occlusion produces zones of severe ischaemia with negligible residual flow. Verification is therefore achieved by showing that a volume of ischaemic, infarcted, or reperfused tissue has been produced in each preparation, and quantification should show this to be of acceptable magnitude. l 3 In animals (for example, cats and dogs) whose hearts often have extensive collateral communications and residual flow it cannot be assumed that ischaemia is effectively maximal for any experimental condition, and evidence of the severity of ischaemia must be provided. Although there is abundant evidence that electrophysiological and biochemical variables change with time during i~chaemia,'~ l 5 there is at University of Saskatchewan on September 29, 2010 cardiovascres.oxfordjournals.org Downloaded from insufficient evidence to justify the routine measurement of any of these as a quantitative index of the severity of ischaemia. The only index that could be accepted as quantitative for species with residual flow is the measurement of regional blood flow (for example, with microspheres). In pigs there is a good linear relation between the duration of the action potential and myocardial blood flow,I6 but it is not known whether this relation holds for animals with significant residual flow. Measures that have been used as a qualitative index of the severity of ischaemia include: visual inspection for cyanosis and dyskinetic regional wall motion; ST segment elevation; epicardial activation delay; ST-T alternans; regional increases in extracellular potassium concentration, increased local venous lactate concentration.
More work is necessary if cats and dogs are to be used routinely for examining antiarrhythmic interventions in ischaemia, infarction, and reperfusion. In dogs, a large variation in coronary anatomy leads to a striking dependence of the incidence of ischaemia induced arrhythmias on residual flow.17 Disregard of this may have invalidated many past experiments." Which variables should be measured in addition to arrhythmias? (convention 9) The recording of additional variables followed by analysis of covariance is preferable to deliberate regulation of a variable in the first instance. Sources of covariance are known for several models. Ischaemia induced arrhythmias have, for instance, been shown to correlate with serum potassium con~entration'~ and the volume of the ischaemic re ion,13 2o but not with heart rate or blood pressure,2 21 in conscious rats, whereas ST segment changes and arterial blood pressure, but not heart rate or the ischaemic volume, correlate with arrhythmias in anaesthetised greyhounds. 22 In anaesthetised mongrel dogs, variability in ischaemia induced arrhythmias may be accounted for almost exclusively by variations in heart rate, the volume of the ischaemic region, and the severity of reduction of coronary flow within that region. 23 The latter relation is governed by the degree of collateral blood flow. l7 Since not every physiological or biochemical variable can be relevant to arrhythmias more experiments should be undertaken to find out which are important and which can be ignored.
Do anaesthetics and anaesthesia influence arrhythmias? (convention 10)
It is uncertain whether anaesthesia influences arrhythmias; studies are few. Ischaemia induced arrhythmias may not be greatly influenced by anae~thesia,'~ although there are reports to the contrary. 24 Reperfusion induced arrhythmias may be exacerbated by a n a e~t h e s i a .~~ With regard to specific f anaesthetics, only halothane has been consistently reported to possess significant antiarrhythmic activity during early ischaemia26 27; other anaesthetics appear to have no effect,26 although more arrhythmias may occur with pentobarbitone than with morphine-chloralose anaesthesia.28 More emphasis on identifying and reporting the consequences of anaesthesia is recommended. What techniques should be used to detect arrhythmias? (convention I I ) In the intact animal, all the information necessary for the detection of arrhythmias is adequately provided by a single ECG lead with sufficient resolution. For the isolated perfused heart supraventricular and ventricular arrhythmias can be differentiated using a ventricular lead and an oscilloscope, but an additional atrial lead would be an advantage.
Although the ECG may be assessed in conjunction with an ancillary variable (such as cardiac output or mean arterial blood pressure), and in terms of whether or not an arrhythmia was lethal, the ECG itself should be the sole basis for definition, classification, and quantification of arrhythmias. ECG records should be kept for a minimum of seven years (this was an arbitrary decision).
Fast Fourier transform (FFT) of the ECG29 is a
technique that may one day provide an objective basis for the detection of arrhythmias. Further investigation of FFT was recommended.
CLASSIFICATION, QUANTIFICATION, AND ANALYSIS OF ARRHYTHMIAS

Ventricular tachyarrhythmias: is there a lingua franca?
The need for conformity in defining the ventricular tachyarrhythmias is evident from the lack of consistency in published reports. The minimum number of consecutive ventricular premature beats that constitute ventricular tachycardia varies from one study to the next and the distinction between ventricular tachycardia and ventricular fibrillation is usually based on subjective criteria. Should ECG interpretation be model dependent? (convention 12) Despite differences in the ECG patterns of arrhythmias between different models, the classification and quantification of arrhythmias must, apriori, be model independent since the detection of arrhythmias is based solely on the ECG (that is, it is independent of other considerations), and only a common (model independent) system will permit standardisation. How should VPB be dejined? (convention 13) Premature beats of ventricular origin should be known as ventricular premature beats and not by any of the alternative possibilities.
Isolated ventricular premature beats are defined as discrete and identifiable premature QRS complexes (premature in relation to the P wave) (fig 1) . Since bigeminy may be different electrophysiologically from irregularly recurring isolated ventricular premature beats bigeminy should be specified as a variant of ventricular premature beats and recorded as such (fig 2) . How should ventricular tachycardia be defined?
(convention 14) Two or three consecutive ventricular premature beats do not constitute ventricular tachycardia but should be termed a salvo (fig 3) . Ventricular tachycardia is defined as a run of four or more consecutive ventricular premature beats (fig 4) . Ventricular tachycardia is not to be defined in terms of its rate or the prevailing sinus rate, since this would make the definition species dependent and model dependent (and in conflict with conventions 11 and 12).
How should ventricular fibrillation be defined? (convention I S )
In 1887, ventricular fibrillation was used to describe the contractile behaviour of the heart on visual in~pection,~' a practice that would be regarded as primitive today. Despite decades of experience with the ECG ventricular fibrillation still proves to be difficult to define objectively. We defined ventricular fibrillation as a signal for which individual QRS deflections can no longer be distinguished from one another (implying morphological instability) and for which a rate can no longer be measured (fig 5) . This configuration differs from that of asystole, which is represented by a flat signal (implying morphological stability) for which the rate is zero. Is it appropriate to divide ventricular tachycardia and ventricular fibrillation into subcategories? (convention 16) Ventricular tachycardia and ventricular fibrillation may be subcategorised according to their duration and mode of termination (figs 4 and 5 ) . Additional subcategories for ventricular tachycardia only are the regularity of configuration (morphology), the rate (RR interval), and the regularity of rate (fig 4) .
FIG 4 Examples of venrricular tachycardia (VT). Recordings as infig 1 . ( a ) and ( b ) sho\c. sustained VT of regular morphology and rate. ( c ) and ( d ) show non-sustained VT itith regular and irregular morphologies and rates (underlined).
Examples of ventricularfibrillation (VF),
Objective definitions for subcategories are essential. The term torsades de pointes, for example, has been used incorrectly to encompass all forms of polymorphous ventricular tachycardia. Torsades de pointes is difficult to define objectively in terms of an ECG configuration, and since it is not simply a description of an ECG signal it is not an objective description of a ventricular tachyarrhythmia. Moreover, since ventricular tachycardia and ventricular fibrillation now adequately describe all ventricular tachyarrhythmias the use of the term torsades de pointes should be discouraged; if used, the original definition3' should be adhered to. How should quantzjkation of the incidence of arrhythmias be approached? (convention 17) The incidence of arrhythmias should be analysed separately within the main categories of ventricular premature beats, bigeminy, salvo, ventricular tachycardia, and ventricular fibrillation. Whether ventricular tachycardia and ventricular fibrillation are analysed in terms of subcategories is a matter of individual preference. If subcategories are used they must be clearly defined; their analysis should be additional to (not a substitute for) analysis of the main categories. When a rate criterion is specified as part of the subcategorisation of ventricular tachycardia, the rhythms that fail to meet that criterion must be adequately described. As a cautionary note, it is expected that when ventricular tachycardia or ventricular fibrillation is divided into subcategories, a statistical requirement for increasing group sizes will result; an exhaustive analysis of subcategories may be impractical. How should quantijkation of other arrhythmia variables be approached? (convention 18) Quantification of other variables (such as number of ventricular premature beats and duration of ventricular tachycardia and ventricular fibrillation, depends on their frequency distribution characteristics. On this basis, the most appropriate methods of expressing the results can be chosen (for example, Gaussian distributed variables may be expressed as mean(SEM)). Frequency distribution of variables should be examined in all models. Data transformation is a valid manoeuvre for facilitating quantification of variables that would otherwise be non-Gaussian distributed.20 What is the value of arrhythmia scores? (convention
19)
An arrhythmia score constitutes any system in which a ranking scale is applied to raw data. This includes everything from the Lown grading system32 to systems of ranking of outcome33 but excludes direct derivatives (transforms) of raw data such as loglo ventricular premature beats." It is important not to confuse the grading of individuals for prognostic purposes32 with the calculation of group mean scores for "summarising" arrhythmias. l 3 Whereas the former is a practice which is inappr~priate,~~ the latter is merely a technique for statistical manipulation and model building. The danger that arrhythmia scores may be misused (to suggest that an intervention is effective when there are no significant effects on the raw data) was acknowledged, but the proscription of their use was considered to be inappropriate.
Various systems of arrhythmia scoring exist.I3 However, their use may be based on fundamental assumptions, not all of which have been substantiated. For example, a Gaussian distributed score (which is suitable for parametric statistical analysis) implies that ventricular premature beats, ventricular tachycardia, and ventricular fibrillation are part of a continuum,20 and this may not be so. Therefore, the use of arrhythmia scores should be approached with caution. Now should statistical analysis be approached?
(convention 20)
Specific statistical tests are not discussed here; the reader should refer to reviews of statistical methodoi~gy.~'-~~ However. some generalities are worthy of note.
It is unacceptable to complete a study and then select a test to show statistical significance. Statistical procedures must be decided before an experiment is begun and be integrated into the study design. Parametric tests require equal group sizes. The minimum group size necessary to test a hypothesis may be determined only if the incidence of arrhythmias in the population (that is, in controls) is known. Statistically appropriate group sizes may be selected by the use of standard formulae or tables ( fig  6) . There will be a different, but definable, minimum group size for each model in relation to each variable. HOW does censoring influence the outcome of an experiment? (convention 21) Loss of animals (for example, from ventricular fibrillation before the end of an experiment) may invalidate statistical analyses and falsify the interpretation of results.3x Censoring of this type may be minimised by: ( a ) defibrillating the heart; ( b ) replacing lost preparations; and ( c ) using specialised statistical tests with missing data subroutines. The approach to be used must, nevertheless, be decided before the experiment is begun and be integrated into the study design. Preparations excluded from a study must be accounted for, and all subgroups created by censoring must be described and analysed separately.
Censoring is inherent in arrhythmia studies. The contiguous occurrence of ventricular premature beats, ventricular tachycardia, and ventricular fibrillation means that one arrhythmia will tend to usurp the occurrence of the others and the most stable (ventricular fibrillation) will dominate. If stable arrhythmias are prevented then the incidence of less stable arrhythmias may appear to increase.
Certain examples of censoring are inherently model specific. Studies of reperfusion induced arrhythmias, for example, suffer from censoring associated with ischaemia induced arrhythmia^.^^ Arrhythmias occumng after reperfusion cannot be classed as reperfusion induced if the heart is not in sinus rhythm at the moment of reperfusion. There are no established methods for dealing with this. The options are replacement of preparations and cardioversion before reperfusion.
Conclusion
The object of establishing conventions for the study of arrhythmias in ischaemia, reperfusion, and infarction is to improve comparability between laboratories. We encourage adoption of the Lambeth Conventions and hope that their validity will be tested by experiment. (1) Their use must never be seen as a substitute for large group sizes. Arrhythmia scores must never be emphasised more than the basic arrhythmia data in order to reach a conclusion that is not supported by the basic data. Arrhythmia scores must never be used as a substitute for the basic data. (20) The statistical procedures necessary to test a hypothesis must be decided before the start of an experiment. Minimum group sizes must be determined in relation to the frequency of Occurrence of the variables of interest. Use of equal group sizes facilitates parametric testing. (21) Censoring (from intraexperimental loss of animals) may jeopardise the analysis and interpretation of an experiment. Three solutions to the problem of censoring from lethal VF are proposed: defibrillation; replacement of lost preparations; use of statistical tests with missing data subroutines. Further experiments are recommended to examine these suggestions. Methods for dealing with censoring must be determined before the start of a study; detailed reporting is mandatory, and all subgroups created by censoring must be identified and analysed separately.
SUMMARY OF CONVENTIONS
We thank the British Heart Foundation, Lorex 
